# Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

> **NCT04472806** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 31 (estimated)

## Conditions studied

- Mucosal Melanoma

## Interventions

- **DRUG:** Toripalimab
- **DRUG:** chemotherapy in combination with Endostar

## Key facts

- **NCT ID:** NCT04472806
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-20
- **Primary completion:** 2022-06-20
- **Final completion:** 2023-06-20
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2020-07-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04472806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04472806, "Maintenance Treatment of Toripalimab(JS001) in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04472806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*